Systemic Inflammation and Obstructive Sleep Apnea Syndrome: Effect of Atorvastatin
Status:
Terminated
Trial end date:
2013-02-01
Target enrollment:
Participant gender:
Summary
The aim of this clinical trial is to evaluate the effect of Atorvastatin on the endothelial
function improvement during the obstructive sleep apnea syndrome (OSAS) after 3 months of
treatment, by a double-blind, randomized, placebo-controlled, multi-center study.
An interim analysis will be performed when 25 patients per group will be included.